Nanotomer, Inc

Website
200 Clarendon St Ste 1700
Boston, MA 02116

NanoTomer, Inc. is a leading targeted oncology company based in Boston, MA. Founded in 2015, their team of dedicated scientists has been at the forefront of developing innovative and cutting-edge technologies to improve patient outcomes. With a focus on addressing unmet needs in the oncology space, NanoTomer, Inc. has become a trusted provider of antibody protein drug conjugates, offering big picture insights that industry leaders depend on.

Through their proprietary antibodies, such as MHA112 and Protin101, NanoTomer, Inc. enables the targeted delivery of highly potent pharmaceuticals directly to cancerous tumors and metastatic sites. Their groundbreaking research and development efforts have the potential to revolutionize cancer therapy, autoimmune disease treatment, and CAR-T therapy. As NanoTomer, Inc. continues to achieve new milestones, they remain committed to pushing the boundaries of targeted oncology and improving the lives of patients worldwide.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesMassachusettsBostonNanotomer, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.